Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
396 5 |
Ultima descărcare din IBN: 2022-12-09 12:10 |
Căutarea după subiecte similare conform CZU |
618.11-006-07-089-053.2/.7 (1) |
Științe medicale. Medicină (11136) |
SM ISO690:2012 HAREA, Patricia, MISHINA, Ana, HAREA, Adrian, DOBREVA, Cristina, FUIOR-BULHAC, Liliana, PETROVICH, Virgil. Diagnosis and surgical treatment of ovarian tumors in pediatric patients.. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2020, nr. 4(68), p. 305. ISSN 1857-0011. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale | ||||||
Numărul 4(68) / 2020 / ISSN 1857-0011 | ||||||
|
||||||
CZU: 618.11-006-07-089-053.2/.7 | ||||||
Pag. 305-305 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Purpose: Ovarian tumors (OT) in pediatric patients are quite rare. The aim was to study the structure, particularities of the diagnosis and surgical treatment of OT in pediatric patients. Methods: The database (n=132) of OT was studied in children and adolescents, operated between 2000 and 2019. USG, CT or MRI were used for the diagnosis and stratification of OT. Selectively, tumor markers (CA 125, CEA, CA 19.9, αFP and β-hCG) were determined. Results: The mean age of patients with OT was 16.1±0.2 years (95% CI:15.64–16.41), including in 5(3.8%) cases patients were in premenarhal status. According to the radiological methods, the maximum dimensions of the OT were 9.9±0.4 cm (from 3.8 to 32.1), and the minimum –7.9±0.3 cm (from 2.6 to 26.5) and the volume – 624.8±106.3 cm3. By size OT were referred to the large (>8 cm accoding Amies Oelschlager AM. et al., 2016) in 64(48.5%) cases and giant (>15 cm accoding Ye LY. et al., 2012) – 14 (10.6%). The USG „morphological” index was 5.5±0.2 (from 2 to 10), and the score ≥5 was in 98 (74.2%) cases. Unilateral OTs were recorded more often than bilateral ones (95.5% vs. 4.5%). Surgery was performed by laparotomy (n=100, 75.8%) and laparoscopy (n=32, 24.2%). By volume, tumorectomies with ovarian tissue preservation – 105 (76.1%), anexectomies – 23 (16.7%), ovarectomies – 9(6.5%) and partial resection of the ovaries – 1 (0.7%). Tumorectomies were performed more frequently via laparoscopy compared to laparotomies – 93.8% vs. 75% (p<0.05). At the histological examination was established that in 130 (94.2%) cases OT were benign, and malignant and borderline – 8 (5.8%). Among the benign tumors predominated were epithelial tumors (n = 72, 55.4%) and germinogenic tumors (n = 53, 40.8%). Relapses in the late postoperative period were in 5 (4.7%) cases. Conclusions: In pediatric patients more commonly benign OT are encountered. In more than half of cases, OT are large and giant. In most cases it is possible to perform tumorectomies with preservation of ovarian tissue. |
||||||
Cuvinte-cheie tumor, ovary, children, adolescents |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-132448</cfResPublId> <cfResPublDate>2020-12-30</cfResPublDate> <cfVol>68</cfVol> <cfIssue>4</cfIssue> <cfStartPage>305</cfStartPage> <cfISSN>1857-0011</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/132448</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>Diagnosis and surgical treatment of ovarian tumors in pediatric patients.</cfTitle> <cfKeyw cfLangCode='EN' cfTrans='o'>tumor; ovary; children; adolescents</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'><p>Purpose: Ovarian tumors (OT) in pediatric patients are quite rare. The aim was to study the structure, particularities of the diagnosis and surgical treatment of OT in pediatric patients. Methods: The database (n=132) of OT was studied in children and adolescents, operated between 2000 and 2019. USG, CT or MRI were used for the diagnosis and stratification of OT. Selectively, tumor markers (CA 125, CEA, CA 19.9, αFP and β-hCG) were determined. Results: The mean age of patients with OT was 16.1±0.2 years (95% CI:15.64–16.41), including in 5(3.8%) cases patients were in premenarhal status. According to the radiological methods, the maximum dimensions of the OT were 9.9±0.4 cm (from 3.8 to 32.1), and the minimum –7.9±0.3 cm (from 2.6 to 26.5) and the volume – 624.8±106.3 cm3. By size OT were referred to the large (>8 cm accoding Amies Oelschlager AM. et al., 2016) in 64(48.5%) cases and giant (>15 cm accoding Ye LY. et al., 2012) – 14 (10.6%). The USG „morphological” index was 5.5±0.2 (from 2 to 10), and the score ≥5 was in 98 (74.2%) cases. Unilateral OTs were recorded more often than bilateral ones (95.5% vs. 4.5%). Surgery was performed by laparotomy (n=100, 75.8%) and laparoscopy (n=32, 24.2%). By volume, tumorectomies with ovarian tissue preservation – 105 (76.1%), anexectomies – 23 (16.7%), ovarectomies – 9(6.5%) and partial resection of the ovaries – 1 (0.7%). Tumorectomies were performed more frequently via laparoscopy compared to laparotomies – 93.8% vs. 75% (p<0.05). At the histological examination was established that in 130 (94.2%) cases OT were benign, and malignant and borderline – 8 (5.8%). Among the benign tumors predominated were epithelial tumors (n = 72, 55.4%) and germinogenic tumors (n = 53, 40.8%). Relapses in the late postoperative period were in 5 (4.7%) cases. Conclusions: In pediatric patients more commonly benign OT are encountered. In more than half of cases, OT are large and giant. In most cases it is possible to perform tumorectomies with preservation of ovarian tissue.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-47046</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-28060</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-90092</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-88597</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-33839</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-33255</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-47046</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-47046-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> <cfFamilyNames>Харя</cfFamilyNames> <cfFirstNames>Патричия</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-28060</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-28060-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> <cfFamilyNames>Mishina</cfFamilyNames> <cfFirstNames>Ana</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-90092</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-90092-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> <cfFamilyNames>Harea</cfFamilyNames> <cfFirstNames>Adrian</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-88597</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-88597-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> <cfFamilyNames>Добрева</cfFamilyNames> <cfFirstNames>К.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-33839</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-33839-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> <cfFamilyNames>Фуйор-Булхак</cfFamilyNames> <cfFirstNames>Лилиана</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-33255</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-33255-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-12-30T24:00:00</cfStartDate> <cfFamilyNames>Petrovich</cfFamilyNames> <cfFirstNames>Virgil</cfFirstNames> <cfFamilyNames>Петрович</cfFamilyNames> <cfFirstNames>Виржил</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>